
Please try another search
QIAGEN Marseille S.A., a molecular diagnosis company, develops and markets diagnostic tests in the field of oncology worldwide. The company offers diagnostic kits and biomarkers. Its products are used in the diagnosis, prognosis, and monitoring of patients with leukemia. The company was formerly known as IPSOGEN S.A. and changed its name to QIAGEN Marseille S.A. in January 2013. The company was founded in 1999 and is headquartered in Marseille, France. Qiagen Marseille Société Anonyme operates as a subsidiary of Qiagen N.V.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review